Western Australian Health and Medical Life Sciences Industry Growth Plan 2020 – 2025
Following the successful missions led by the Deputy Premier to Israel and BIO2019 last year to explore opportunities for health and medical innovation in Western Australia (WA), the Department of Jobs, Tourism, Science and Innovation (JTSI) is developing a Health and Medical Life Sciences Industry Growth Plan (plan) for WA. Read the
media statement here.
To be developed in collaboration with the WA Department of Health (DoH) and led by the Deputy Premier with support from the Minister for Innovation and ICT, the plan will enable WA to capitalise on the growing needs of the global health and medical life sciences market, and support the creation of jobs and international trade and investment opportunities.
It will further build upon WA’s competitive advantages to position the health and medical life sciences sector as a world-leading, sustainable, value-adding industry that diversifies the State’s economy and enables positive change across the WA health system through innovation.
To be released during 2020, the plan will provide a clear set of actions to stimulate and strengthen WA’s health and medical life sciences industry and innovation sectors over the next five years.
Steering Committee
A Steering Committee will provide strategic direction and advice on the development of the plan. This will be chaired by the Deputy Premier and Minister for Health, Hon. Roger Cook MLA, and include the Chief Scientist of WA, Professor Peter Klinken AC, the Directors General of JTSI and DoH, and national industry representatives, Ms Sue MacLeman – Chair of MTPConnect and Ms Michelle Burke – Deputy Chair, AusBiotech.
Industry Reference Group
An Industry Reference Group chaired by the Chief Scientist of WA has been established with representatives from across the sector. The Industry Reference Group will draw on their diverse expertise and experience in the industry to provide guidance on the directions of the plan.
Industry Reference Group members:
- Mr Abdul Ekram (Senior Trade Advisor and A/Manager of International Health, Austrade) providing expertise in international trade and investment for the health sector.
- Ms Angela Doyle (WA State Director, Advanced Manufacturing Growth Centre) providing expertise in advanced manufacturing.
- Mr Colin La Galia (Chief Executive Officer, Epichem) providing expertise in international markets and pharmaceuticals.
- Dr Debra Cousins (Executive Director, Science and Innovation, Department of Jobs, Tourism, Science and Innovation) providing expertise in government policy, innovation and the life sciences sector.
- Mr Gary Cox (Chairman and Principal, Wrays) providing expertise in intellectual property development for the life sciences sector.
- Mr Justin Stillitano (Commercial Leader, Pfizer) providing expertise in pharmaceuticals, manufacturing and business development.
- Dr Kath Giles (Chief Executive Officer & Managing Director, OncoRes Medical) providing expertise in commercialisation and life science sector investment.
- Ms Liddy McCall (Co-Founder & Investment Director, Yuuwa Capital) providing expertise in investment, start-ups and commercialisation.
- Dr Liz Dallimore (Director, WA Data Science Innovation Hub) providing expertise in data, innovation and commercialisation.
- Mr Michael Pasquale (Economic Development Officer, City of Perth) providing expertise in WA’s medical life sciences sector.
- Dr Michael Winlo (Chief Executive Officer, Emerald Clinics) providing expertise in clinical trials and digital health.
- Adjunct Professor Paul Watt (Director of Research Services and Innovation, Telethon Kids Institute) providing expertise in pharmaceuticals, technology transfer and licensing, and experience working within a medical research institute.
- Ms Robyn Sermon (Executive Director, Innovation and Development, WA Country Health Service) providing expertise in WA health system innovation and innovation in regional and remote areas.
- Dr Samantha South (Chair of AusBiotech’s WA State Committee) providing expertise in commercialisation and links to AusBiotech.